Cyfuse Biomedical
Tokyo, JP · 3 known investors
Find your way into Cyfuse Biomedical
Sign up to see every warm intro you have to Cyfuse Biomedical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cyfuse Biomedical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cyfuse Bio develops 3D cell-based tissue and organ products created from cells alone, without artificial materials, for transplantation to restore original tissue and organ function in regenerative medicine applications.
Investors · 3
SMBC Venture Capitallisted by SMBC Venture CapitalTokyovia Hiroya Ota · inferred
How we know: SMBC Venture Capital's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Cyfuse Biomedical do?
- Cyfuse Bio develops 3D cell-based tissue and organ products created from cells alone, without artificial materials, for transplantation to restore original tissue and organ function in regenerative medicine applications.
- Who are Cyfuse Biomedical's investors?
- Cyfuse Biomedical's investors include DBJ Capital, Nippon Venture Capital, SMBC Venture Capital.
- Where is Cyfuse Biomedical headquartered?
- Cyfuse Biomedical is headquartered in Tokyo, JP.
